🌱 KidneyEnergy.com

← brief for 2026-09-25 · People & money

Implicit Rationing of Incretin Therapy in Diabetic Kidney Disease: A Call for Deliberate Allocation.

Article No results yet Not peer reviewed

Key takeaways

This is an opinion piece about the cost of diabetes drugs. It argues that people with kidney disease often cannot afford these drugs. The drugs are expensive and are often sold for weight loss instead. It is a discussion, not a study with new data.

Who did this work

de Silva D · Peiris A

Source

Article · PubMed, the drug frontier · 2026 Aug 25
https://pubmed.ncbi.nlm.nih.gov/42787678/